Biogen to acquire Apellis Pharmaceuticals for $5.6 billion or $41/sh plus CVR
Tweet Send to a Friend
(Updated - March 31, 2026 6:50 AM EDT)
Biogen Inc. (NASDAQ: BIIB) has agreed to acquire Apellis Pharmaceuticals Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Biogen Inc. (NASDAQ: BIIB) has agreed to acquire Apellis Pharmaceuticals Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
